Table of Contents
introduction
limited cutaneous systemic scleroderma
diffuse scleroderma
scleroderma
see also:
connective tissue (CT) disorders
ENA (extractable nuclear antigen)
autoimmune disease
introduction
scleroderma is a autoimmune
connective tissue disorder
characterised by “hardening” of the skin +/- internal organs
there is currently no curative treatment for the disease itself
limited cutaneous systemic scleroderma
features mainly limited to skin and oesophagus, formerly called
CREST
:
C
alcinosis (the deposition of calcium nodules in the skin)
R
aynaud's phenomenon
E
sophageal dysfunction
S
clerodactyly (skin thickening on the fingers)
T
elangiectasias (dilated capillaries on the face, hands and mucous membranes)
diffuse scleroderma
rapidly progressive severe form involving large areas of skin and end organs which may cause:
dry, persistent cough due to interstitial lung disease
progressive shortness of breath and/or chest pain due to pulmonary artery hypertension
cardiac conduction issues
hypertension
cardiac failure
gastro-oesophageal reflux
SICCA (xerostomia and keratoconjunctivitis)
erectile dysfunction, dyspareunia
chronic renal failure
neurologic symptoms incl. trigeminal neuralgia, carpal tunnel, headaches, stroke, fatigue
5yr survival is 70% while 10 year survival is 55%